series-c-plus
Stage
1
Investors
About
Provigate, Inc develops low- and non-invasive home self-monitoring devices and an app for weekly glycoalbumin blood glucose testing, aiming to support behavior change and diabetes and prediabetes management.
Explore Provigate, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.